| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for ArQule Inc. > News item |
ArQule shareholder Biotechnology Value Fund has 29.65% ownership interest
By Lisa Kerner
Charlotte, N.C., Nov. 26 - Biotechnology Value Fund, LP upped its stake in ArQule, Inc. to 29.65% with the purchase of 676,313 shares on Nov. 19 and Nov. 21.
The shares purchased on Nov. 19 were priced at $2.65 apiece, and those purchased on Nov. 21 were priced at $2.3952 each, it was reported in a schedule 13D/A filed with the Securities and Exchange Commission.
Biotechnology Value Fund acquired 2,255,700 shares of ArQule between Nov. 10 and Nov. 12 priced from $2.25 to $2.45 each, a prior SEC filing said.
The investor beneficially owns approximately 13 million shares of the Woburn, Mass., biotechnology company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.